Neurology News

Pregnancy-related MS relapses were associated with early natalizumab withdrawal among women before and during pregnancy, according to a study published in JAMA Network Open.

Pregnancies complicated by migraines are associated with adverse outcomes for both women and their babies, according to a presentation at The Pregnancy Meeting.

Vamorolone maintained muscle strength and function, as well as improved height velocity, compared with glucocorticoid therapy among those with Duchenne muscular dystrophy, according to data published in JAMA Network Open.

The National Institute of General Medical Sciences, a division of the NIH, awarded $1.8 million to Integrated Micro-Chromatography Systems Inc. for phase 2 of its fast track Small Business Innovation Research grant, according to a release.

Commencing long-term dual antiplatelet therapy with cilostazol no less than 15 days after stroke proved to be a stronger method of secondary stroke prevention than standard monotherapy, according to study results published in Neurology.

Increases in generalized and visceral adipose tissue were linked to reduction of cognitive function in adults, when adjusted for other health factors, per a Canadian cross-sectional cohort study published in JAMA Network Open.

The nonprofit Women in Medicine recently launched an all-women speakers bureau to increase opportunities for female experts in medicine. It is the first of its kind, according to the organization.

Beginning in early spring, beneficiaries of original Medicare and Medicare Advantage plans will be eligible to receive free over-the-counter COVID-19 tests, according to CMS.

The COVID-19 pandemic has significantly altered delivery of developmental services among children with acute provoked neonatal seizures, according to results of a prospective cohort study published in Pediatric Neurology.

The FDA granted orphan drug designation to PharmaTher for its status epilepticus ketamine treatment, according to a company press release.